For example, at the 60-90 day followup time point the infection rate in the low-baseline group ranked by IgG levels to RBD mutants, and IgA levels to VOCs, was 42.1% and only 13% in the high-baseline group in the fourth dose group (HR = 8.18, p = 0.018). The gene discussed is CD79A; the disease is infection.